Company news
Clinical Laserthermia Systems Ab Class B (OMXSTO:CLS_B) news
Clinical Laserthermia Systems Ab Class B news releases on 6ix. Latest, May 28, 2026: CLS Enters Research Agreement With U.S. National Cancer Institute
Press releases & updates
CLS Enters Research Agreement With U.S. National Cancer Institute
May 28, 2026
Sweden's CLS Q1 sales fall 72% after partner talks
May 12, 2026
CLS Receives Order Worth SEK 23 Mln For Prism Business
May 11, 2026
Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
February 20, 2026
CLS Initiates Recruitment Process For Permanent Chief Financial Officer
December 12, 2025
Clinical Laserthermia Systems Q3 Revenue SEK 2.8 Mln
November 14, 2025
CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results
October 7, 2025
Clinical Laserthermia Systems AB: Quarterly Trading Report 2025 Q3
October 3, 2025
CLS Raises SEK 20.9 Mln Through Full Subscription Of Warrants
September 30, 2025
CLS_B: Record Q2 sales and improved margins drive narrowed losses and strong growth outlook
August 22, 2025
CLS_B: Revenue up 43% and operating loss halved as CLS accelerates neurosurgery commercialization
May 16, 2025
CLS_B: CLS doubled sales, improved margins, and refocused on neurosurgery for high-margin growth
February 21, 2025
CLS_B: CLS accelerates neurosurgery growth, narrows losses, and targets profitability by 2026
October 31, 2024
CLS_B: Revenue quadrupled and losses narrowed as neurosurgery focus and US expansion accelerated
August 23, 2024